Mediceles Secures Three Major Awards at 2026 Medytox Global Symposium
Thai company Mediceles has been recognized with three prestigious awards at the 2026 Medytox Global Symposium in Seoul, marking its third consecutive year of success.
According to Prachachat Business, the Thai firm Mediceles has achieved significant international recognition by winning three major awards at the 2026 Medytox Global Symposium held in Seoul, South Korea. The company secured the Best Performance Award, the Best Partner Award, and the Best KOL Award, outperforming partners from over 60 countries worldwide. This achievement marks the third consecutive year that Mediceles has maintained its leading position within the global network. For residents and business observers in Thailand, this success highlights the growing influence of local health and aesthetic distribution firms on the global stage. The company has also announced its strategic roadmap for 2027, which includes the introduction of new product lines to the market. While the company has outlined its intent to expand its portfolio, specific details regarding the nature of these upcoming products and their potential impact on local availability remain to be confirmed. This development underscores the company's ongoing growth trajectory in the competitive medical aesthetics sector.
